Successful Treatment of T-cell Post-Transplant Lymphoproliferative Disorder with the Retinoid Analog Bexarotene
نویسندگان
چکیده
منابع مشابه
Post-transplant lymphoproliferative disorder.
BACKGROUND Posttransplant lymphoproliferative disorder (PTLD) is increasingly recognized as a serious complication of solid organ transplantation in both children and adults. Factors associated with increased risk of PTLD include mismatch of recipient and donor EBV serologic status (seronegative recipient with seropositive donor), and intensive drug-induced immunosuppression. METHODS AND RESU...
متن کاملOcular post-transplant lymphoproliferative disorder
We report a case of an iris tumor with muttonfat keratic precipitates in a young patient after liver transplantation surgery. A 6yearold girl underwent liver transplantation for congenital biliary atresia and was subsequently immunosuppressed with oral cyclosporine. We examined her 5 years after transplantation because of a "white nodule in her left eye," which had been detected by her father o...
متن کاملPost-transplant Lymphoproliferative Disorder--a case of late-onset T-cell lymphoma after failed renal transplant.
Post-transplant lymphoproliferative disease (PTLD) is a rare but life-threatening complication after solid organ transplantation. The risk of PTLD varies with recipient age, serostatus of the donor and the recipient for Epstein-Barr virus, type of organ transplanted, and intensity of immunosuppression. The risk of PTLD is highest in the early post-transplant period, but the cumulative risk incr...
متن کاملSuccessful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (EBV-PTLD) is a complication of hematopoietic stem cell transplantation (HSCT). Standard initial treatment of patients with EBV-PTLD includes administration of rituximab or dose reduction of a calcineurin inhibitor. We report successful chemotherapeutic treatment of rituximab-resistant EBV-PTLD after HSCT in a pati...
متن کاملAggressive T-cell Large Granular Lymphocytic Leukemia Presenting as an EBV Negative Post-Transplant Lymphoproliferative Disorder
A 33 year-old man, a renal transplant recipient, developed an aggressive T-cell large granular lymphocytic leukemia (LGL) that presented as a soft-tissue lesion, mimicking an abscess. The tumor cells showed cytological features of large granular lymphocytes, immunophenotypically characterized as mature T-cells expressing CD2, CD5, CD4, CD56, and TIA-1. About 80% of tumor cells were positive for...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Transplantation
سال: 2005
ISSN: 1600-6135,1600-6143
DOI: 10.1111/j.1600-6143.2005.00948.x